159885-63-9 Usage
Uses
Used in Pharmaceutical Industry:
ETHYL 1-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE is used as a drug candidate for its potential therapeutic properties. Its unique chemical structure may contribute to the development of new medications, particularly in the treatment of various diseases and conditions.
Used in Agrochemical Industry:
In the agrochemical sector, ETHYL 1-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE is used as a building block for the synthesis of agrochemicals. Its chemical properties may be harnessed to create new pesticides, herbicides, or other agricultural chemicals that can improve crop protection and yield.
Used in Materials Science:
ETHYL 1-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE is utilized in materials science for the development of novel materials with specific properties. Its unique molecular structure may be key in creating advanced materials for various applications, such as sensors, catalysts, or other specialized uses.
Further research and testing are necessary to fully explore and understand the potential of ETHYL 1-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE in these and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 159885-63-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,8,8 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 159885-63:
(8*1)+(7*5)+(6*9)+(5*8)+(4*8)+(3*5)+(2*6)+(1*3)=199
199 % 10 = 9
So 159885-63-9 is a valid CAS Registry Number.
159885-63-9Relevant academic research and scientific papers
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen- mediated platelet aggregation
Sanfilippo,Urbanski,Beers,Eckardt,Falotico,Ginsberg,Offord,Press,Tighe,Tomko,Andrade-Gordon
, p. 34 - 41 (2007/10/02)
The synthesis and biological activity of novel thiazole-based heterocycles as inhibitors of thrombin-induced human platelet aggregation are described. Further evaluation of selected compounds show they inhibit platelet aggregation as stimulated by a varie
